BCD Innovations, Inc. develops novel methods for the prediction, detection, and treatment of cancer. We are dedicated to the commercialization of transformative approaches using patented genetic analysis technologies. BCD’s Plain Yard Test™ is a highly accurate molecular test for the diagnosis of bladder cancer that launched in the market this year.
Looking for a particular BCD Innovations employee's phone or email?
The BCD Innovations annual revenue was $5.2 million in 2026.
BCD Innovations is based in Baltimore, Maryland.
The NAICS codes for BCD Innovations are [621, 541, 54, 62].
The SIC codes for BCD Innovations are [8071, 873, 807, 87, 80].